Sudhir P. Kasturi, Ph.D.

Affiliations: 
2006 University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
Biomedical, Cell Biology
Google:
"Sudhir Kasturi"

Parents

Sign in to add mentor
Krishnendu Roy grad student 2006 UT Austin
 (Design, synthesis, and evaluation of synthetic particulate delivery systems in DNA and protein vaccine delivery.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bollimpelli VS, Reddy PBJ, Gangadhara S, et al. (2023) Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques. Nature Communications. 14: 4789
Pino M, Abid T, Pereira Ribeiro S, et al. (2021) A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Science Immunology. 6
Kasturi SP, Rasheed MAU, Havenar-Daughton C, et al. (2020) 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates. Science Immunology. 5
Arunachalam PS, Charles TP, Joag V, et al. (2020) T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers. Nature Medicine
Chen YG, Chen R, Ahmad S, et al. (2019) N6-Methyladenosine Modification Controls Circular RNA Immunity. Molecular Cell
Petitdemange C, Kasturi SP, Kozlowski PA, et al. (2019) Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques. Jci Insight. 4
Burton S, Spicer LM, Charles TP, et al. (2019) Clade C HIV-1 envelope vaccination regimens differ in their ability to elicit antibodies with moderate neutralization breadth against genetically diverse tier 2 HIV-1 envelope variants. Journal of Virology
Klasse PJ, Ketas TJ, Cottrell CA, et al. (2018) Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. Plos Pathogens. 14: e1006913
Kasturi SP, Kozlowski PA, Nakaya HI, et al. (2016) Adjuvanting an SIV vaccine with TLR ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5α restrictive macaques. Journal of Virology
Havenar-Daughton C, Carnathan DG, Torrents de la Peña A, et al. (2016) Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer. Cell Reports. 17: 2195-2209
See more...